• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Managing opioid use disorder in primary care: PEER simplified guideline.初级保健中阿片类药物使用障碍的管理:PEER简化指南。
Can Fam Physician. 2019 May;65(5):321-330.
2
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.开发阿片类药物使用障碍的临床决策支持:NIDA 临床试验网络工作组报告。
Addict Sci Clin Pract. 2020 Jan 16;15(1):4. doi: 10.1186/s13722-020-0180-2.
3
Methodological quality of guidelines for the management of opioid use disorder: A systematic review.方法学质量的指导方针管理阿片类药物使用障碍:系统评价。
J Clin Pharm Ther. 2021 Dec;46(6):1531-1548. doi: 10.1111/jcpt.13449. Epub 2021 Jun 22.
4
Treatment of opioid use disorder in primary care.在初级保健中治疗阿片类药物使用障碍。
BMJ. 2021 May 19;373:n784. doi: 10.1136/bmj.n784.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.宾夕法尼亚州农村获取 MAT(RAMP):一项混合实施研究方案,旨在促进农村初级保健提供者采用药物辅助治疗。
Addict Sci Clin Pract. 2019 Aug 1;14(1):25. doi: 10.1186/s13722-019-0154-4.
7
Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.识别接受药物辅助治疗的阿片类药物使用障碍患者的患者重要结局:系统评价方案。
BMJ Open. 2018 Dec 4;8(12):e025059. doi: 10.1136/bmjopen-2018-025059.
8
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.临床实践指南:常见耳鼻喉科手术后镇痛的阿片类药物处方。
Otolaryngol Head Neck Surg. 2021 Apr;164(2_suppl):S1-S42. doi: 10.1177/0194599821996297.
9
Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?在医疗实践中开具丁丙诺啡治疗阿片类药物使用障碍:基于诊室的门诊治疗能否解决美国的阿片类药物危机?
Addiction. 2019 Nov;114(11):1992-1999. doi: 10.1111/add.14733. Epub 2019 Jul 25.
10
A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder.一项关于临床决策支持工具改善阿片类药物使用障碍初级治疗的功能和临床医生接受度的初步研究。
Addict Sci Clin Pract. 2021 Jun 15;16(1):37. doi: 10.1186/s13722-021-00245-7.

引用本文的文献

1
Retention in Opioid Agonist Therapy Among First Nations People.原住民接受阿片类激动剂治疗的留存情况。
JAMA Netw Open. 2025 Jun 2;8(6):e2518452. doi: 10.1001/jamanetworkopen.2025.18452.
2
[Not Available].[无可用内容]
CMAJ. 2025 Apr 13;197(14):E400-E402. doi: 10.1503/cmaj.250094-f.
3
Preventing harms from first prescriptions of opioids.预防阿片类药物首次处方带来的危害。
CMAJ. 2025 Feb 9;197(5):E133-E134. doi: 10.1503/cmaj.250094.
4
Reframing conceptualizations of primary care involvement in opioid use disorder treatment.重新构建初级保健在阿片类药物使用障碍治疗中的参与概念。
BMC Prim Care. 2024 Sep 30;25(1):356. doi: 10.1186/s12875-024-02607-x.
5
Medical training to effectively support patients who use substances across practice settings: a scoping review of recommended competencies.在各种医疗环境中有效支持使用药物的患者的医学培训:推荐能力的范围综述
Can Med Educ J. 2024 Jul 12;15(3):73-96. doi: 10.36834/cmej.75973. eCollection 2024 Jul.
6
Low-dose Initiation of Buprenorphine/naloxone for the Management of Chronic Non-cancer Pain in Patients on Long-term Opioid Therapy: A Case Series.低剂量起始丁丙诺啡/纳洛酮用于长期阿片类药物治疗患者慢性非癌性疼痛的管理:病例系列
Can J Pain. 2024 Jan 26;8(1):2310811. doi: 10.1080/24740527.2024.2310811. eCollection 2024.
7
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review.考察阿片类激动剂治疗 (OAT) 口服剂量 (THD) 可及性方面的不平等:加拿大 OAT 指南综合与系统评价。
Int J Drug Policy. 2024 May;127:104343. doi: 10.1016/j.drugpo.2024.104343. Epub 2024 Mar 29.
8
Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review.了解远程医疗在不同阿片类药物使用障碍治疗模式中的应用:一项范围综述。
J Telemed Telecare. 2025 May;31(4):500-514. doi: 10.1177/1357633X231195607. Epub 2023 Sep 4.
9
Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement: Perspectives from Prescribers of Medications for Opioid Use Disorder.在初级保健中评估和治疗创伤的障碍以及改进的机会:阿片类药物使用障碍药物处方者的观点。
Subst Use Misuse. 2023;58(13):1651-1659. doi: 10.1080/10826084.2023.2238301. Epub 2023 Jul 26.
10
The value of family medicine: An impossible job, done impossibly well.家庭医学的价值:一项不可能完成的工作,却被出色地完成了。
Can Fam Physician. 2023 Apr;69(4):269-270. doi: 10.46747/cfp.6904269.

本文引用的文献

1
Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.初级保健中的阿片类药物使用障碍:对系统评价的PEER综合系统评价
Can Fam Physician. 2019 May;65(5):e194-e206.
2
Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.处方和非处方阿片类药物对阿片类药物相关死亡的影响:加拿大安大略省基于人群的队列研究
BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207.
3
Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.比较加拿大各地处方阿片类药物对阿片类药物相关住院治疗的贡献:一项多司法管辖区的横断面研究。
Drug Alcohol Depend. 2018 Oct 1;191:86-90. doi: 10.1016/j.drugalcdep.2018.06.028. Epub 2018 Jul 31.
4
Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study.初级保健患者慢性非癌性疼痛中阿片类药物滥用的风险——一项横断面研究。
BMC Fam Pract. 2018 Jun 20;19(1):92. doi: 10.1186/s12875-018-0775-9.
5
Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis.接受阿片类镇痛药治疗的疼痛患者发生医源性阿片类药物依赖或滥用的发生率:系统评价和荟萃分析。
Br J Anaesth. 2018 Jun;120(6):1335-1344. doi: 10.1016/j.bja.2018.03.009. Epub 2018 Apr 21.
6
Management of opioid use disorders: a national clinical practice guideline.阿片类物质使用障碍的管理:一项国家临床实践指南。
CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958.
7
Simplified guideline for prescribing medical cannabinoids in primary care.基层医疗中文献中开具医用大麻类药物的简化指南。
Can Fam Physician. 2018 Feb;64(2):111-120.
8
Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study.阿片类药物初治患者的术后处方及其与过量用药和滥用的关联:回顾性队列研究
BMJ. 2018 Jan 17;360:j5790. doi: 10.1136/bmj.j5790.
9
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives.健康计划实施阿片类药物剂量和风险降低举措后,慢性阿片类药物治疗患者中处方阿片类药物使用障碍的患病率。
Int J Drug Policy. 2017 Aug;46:90-98. doi: 10.1016/j.drugpo.2017.05.053. Epub 2017 Jun 27.
10
Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015.2006 - 2015年美国初始处方事件的特征及长期使用阿片类药物的可能性
MMWR Morb Mortal Wkly Rep. 2017 Mar 17;66(10):265-269. doi: 10.15585/mmwr.mm6610a1.

初级保健中阿片类药物使用障碍的管理:PEER简化指南。

Managing opioid use disorder in primary care: PEER simplified guideline.

作者信息

Korownyk Christina, Perry Danielle, Ton Joey, Kolber Michael R, Garrison Scott, Thomas Betsy, Allan G Michael, Bateman Cheryl, de Queiroz Raquel, Kennedy Dorcas, Lamba Wiplove, Marlinga Jazmin, Mogus Tally, Nickonchuk Tony, Orrantia Eli, Reich Kim, Wong Nick, Dugré Nicolas, Lindblad Adrienne J

机构信息

Family physician and Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.

Nurse and Clinical Evidence Expert at the Alberta College of Family Physicians in Edmonton.

出版信息

Can Fam Physician. 2019 May;65(5):321-330.

PMID:31088869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6516701/
Abstract

OBJECTIVE

To use the best available evidence and principles of shared, informed decision making to develop a clinical practice guideline for a simplified approach to managing opioid use disorder (OUD) in primary care.

METHODS

Eleven health care and allied health professionals representing various practice settings, professions, and locations created a list of key questions relevant to the management of OUD in primary care. These questions related to the treatment setting, diagnosis, treatment, and management of comorbidities in OUD. The questions were researched by a team with expertise in evidence evaluation using a series of systematic reviews of randomized controlled trials. The Guideline Committee used the systematic reviews to create recommendations.

RECOMMENDATIONS

Recommendations outline the role of primary care in treating patients with OUD, as well as pharmacologic and psychotherapy treatments and various prescribing practices (eg, urine drug testing and contracts). Specific recommendations could not be made for management of comorbidities in patients with OUD owing to limited evidence.

CONCLUSION

The recommendations will help simplify the complex management of patients with OUD in primary care. They will aid clinicians and patients in making informed decisions regarding their care.

摘要

目的

运用现有最佳证据和共同的、充分知情决策原则,制定一项关于在初级保健中简化阿片类物质使用障碍(OUD)管理方法的临床实践指南。

方法

11名代表不同执业环境、专业和地点的医疗保健及相关健康专业人员列出了与初级保健中OUD管理相关的关键问题清单。这些问题涉及OUD的治疗环境、诊断、治疗以及共病管理。由具有证据评估专业知识的团队通过一系列随机对照试验的系统评价对这些问题进行研究。指南委员会利用这些系统评价制定建议。

建议

建议概述了初级保健在治疗OUD患者中的作用,以及药物治疗和心理治疗及各种处方做法(如尿液药物检测和协议)。由于证据有限,无法针对OUD患者的共病管理提出具体建议。

结论

这些建议将有助于简化初级保健中OUD患者的复杂管理。它们将帮助临床医生和患者就其治疗做出明智决策。